Lundbeck’s Neuro-Rare Pipeline Lands Cornerstone Drug via $2.6B Longboard Pharma Acquisition
Neuroscience drug developer Lundbeck is increasing its scope to epilepsy through the $2.6 billion acquisition of Longboard Prescribed drugs, an ...
Tag: NeuroRare
RECOMMENDED
Global progress on childhood vaccinations is slowing down
Childhood vaccination protection has made leaps since 1980. However progress has considerably slowed within the final 20 years. That's in...
Stay informed with the latest news, articles, and insights on agarwood cultivation, history, sustainability, and more. Explore the timeless allure of agarwood and deepen your understanding of this extraordinary natural resource.